USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/16571
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPrisacari, Viorel
dc.contributor.authorAndronachi, Nicoleta
dc.date.accessioned2021-04-07T08:30:27Z
dc.date.available2021-04-07T08:30:27Z
dc.date.issued2021
dc.identifier.issn2587-3466
dc.identifier.issn2587-3458
dc.identifier.urihttps://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/121/76
dc.identifier.urihttps://doi.org/10/38045/ohrm.2021.2.05
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/16571
dc.descriptionUniversitatea de Stat de Medicină și Farmacie „NicolaeTestemițanu”, Republica Moldovaen_US
dc.description.abstractIntroduction. Acinetobacter baumannii is a pathogen and a major cause of nosocomial infections in the current healthcare system worldwide due to its high resistance to antibiotics, including those considered as a last resort, thus posing threat to severe clinical forms, as well as exhibiting significant economic and clinical impact. Material and methods. A descriptive longitudinal and cross-sectional epidemiological study was carried out based on the model of multidisciplinary care hospitals.Results.The generalized clinical forms of Acinetobacter nosocomial infections predominate in 56.30%, including: pulmonary sepsis – 25.59%, abdominal sepsis – 11.81%, septicemia –9.45%, wound sepsis – 6.30%, biliary sepsis – 1.97%, and urosepsis –1.18% of cases. Local infections were found in 16.93% of wound infections and in 14.57% of pneumonia cases. A. baumanii was present in the etiological structure of 98.18% of cases, exhibiting an increased resistance to antibiotics, particularly to monobactams –100.0%, macrolides – 98.82%, penicillins – 98.08%, cephalosporins – 97.65%, penicillins with beta-lactamase inhibitors – 93.20%, fluoroquinolones – 87.16%, and amphenicols – 84.17% of cases. A. baumanii strains isolated from patients with nosocomial infections were found to be multidrug-resistant to antibiotics in 93.08% of cases. Conclusions. Acinetobacter baumannii nosocomial infections represent a major public health issue that requires the implementation of strict surveillance and control strategies, including the rational use of antibiotics.en_US
dc.description.abstractIntroducere. Acinetobacter baumanii prezintă un agent patogen ce cauzează infecții nosocomiale, devenind, actualmente o amenințare globală de sănătate publică din cauza nivelurilor ridicate de rezistenţă la antibiotice, inclusiv la cele considerate de ultimă instanță, formelor clinice severe, impactului economic şi clinic semnificativ.Material și metode. A fost realizat un studiu epidemiologic descriptiv longitudinal şi transversal pe modelul staționarelor multiprofil. Rezultate. În structura infecțiilor nosocomiale cu Acinetobacter predomină formele clinice generalizate – 56,30%, inclusiv: sepsis pulmonar – 25,59%, sepsis abdominal – 11,81%, septicemii – 9,45%, sepsis tegumentar –6,30%, sepsis colangiogen – 1,97%, sep-sis uronefrogen –1,18%. Din infecțiile locale predomină infecțiile de plagă –16,93% și pneumoniile – 14,57%. În structura etiologică predomină A. baumanii – 98,18%, rezistența la antibiotice fiind sporită, inclusiv la monobactame – 100,0%, macrolide – 98,82%, peniciline – 98,08%, cefalosporine –97,65%, peniciline cu inhibitori de betalac-tamaze – 93,20%, fluorochinolone – 87,16%, amfenicoli - 84,17%. Tulpinile de A. baumanii izolate de la pacienții cu infecții nosocomiale în 93,08% s-au dovedit a fi polirezistente la antibiotice. Concluzii. Infecțiile nosocomiale cu Acinetobacter prezintă astăzi o problemă majoră de sănătate publică și necesită implementarea strategiilor stricte de supraveghere și control, inclusiv a utilizării raționale a antibioticelor.en_US
dc.language.isoroen_US
dc.publisherAsociația de Biosiguranță și Biosecuritate din Republica Moldovaen_US
dc.relation.ispartofOne Health & Risk Managementen_US
dc.subjectAcinetobacter baumannii nosocomial infectionsen_US
dc.subjectantibiotic resistanceen_US
dc.subject.ddcCZU: 616.98:579.841-022.36-036.22en_US
dc.titleStudiu epidemiologic privind infecțiile nosocomiale cu Acinetobacteren_US
dc.title.alternativeEpidemiological study of Acinetobacter baumannii nosocomial infectionsen_US
dc.typeArticleen_US
Appears in Collections:One Health & Risk Management Vol. 2 No 2, 2021

Files in This Item:
File Description SizeFormat 
121_Manuscript_320_1_10_20210406.pdf517.54 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback